MADELYN BOYLE: Open Payments
NPI 1457605214 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 28 payments from 4 companies in 2025. Trend: 2023 $371 · 2024 $731 · 2025 $789
Food & beverage: $639Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $575 |
| Biogen, Inc. | 1 | $150 |
| REVANCE THERAPEUTICS, INC. | 1 | $50 |
| TG Therapeutics, Inc. | 1 | $14 |
Products named: UBRELVY, TYSABRI, DAXXIFY, QULIPTA, BRIUMVI.
Industry payments across MT — which companies pay providers there.
